Virginia Medicaid PDL/CCF and 90-Day Supply List Changes, FDA Approval of OTC Naloxone, and DUR Board Approved Drug SAs

Medicaid Memo | July 6, 2023

The purpose of this memorandum is to notify providers about updates to the Virginia Medicaid’s fee-for-service (FFS) Preferred Drug List (PDL) Program, 90-day supply list, naloxone FDA approval status, and drug service authorization (SA) requirements for drugs reviewed by the Department’s Pharmacy and Therapeutics Committee (P&T) and the Drug Utilization Review (DUR) Board.

See the full memo here, or download the PDF here.